Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025
Wearable Devices Identify Altered Sleep Characteristics and Sleep Trajectories in Active Inflammatory Bowel Disease.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hirten Robert P, Danieletto Matteo, Whang Jessica K, Landell Kyle, Helmus Drew, Said Hyder, Ensari Ipek, Shah Neomi, Bagiella Emilia, Figueiro Mariana G, Sands Bruce E, Suarez-Farinas Mayte
Аннотация
BACKGROUND & AIMS: Poor sleep is associated with flares of inflammatory bowel disease (IBD). Studies often rely on subjective assessments of sleep and disease activity. Our aim is to use wearable devices to objectively assess the impact of inflammation and symptoms on sleep architecture in IBD.
METHODS: Individuals ≥18 years of age, diagnosed with and on medication for IBD, were enrolled in an observational study, answered daily disease activity surveys, and wore a wearable device. Sleep architecture, sleep efficiency, and total hours asleep were collected from the devices. Inflammatory markers were collected as standard of care. Associations between sleep metrics and periods of symptomatic and inflammatory flares and combinations of symptomatic and inflammatory activity were compared with periods of symptomatic and inflammatory remission. The rate of change in sleep metrics for 45 days before and after inflammatory and symptomatic flares was explored.
RESULTS: A total of 101 participants were enrolled contributing a mean duration of 228.16 ± 154.24 nights of wearable data. Periods with active inflammation were associated with a significantly smaller percentage of sleep time in rapid eye movement and a greater percentage of sleep time in light sleep. Evaluating the intersection of inflammatory and symptomatic flares, altered sleep architecture was only evident when inflammation was present, and not with symptoms. Significant differences were observed in the rate that the percentage of time spent in deep and light sleep changed before and after inflammatory and symptomatic flares.
CONCLUSIONS: Impaired sleep architecture is associated with inflammatory activity in IBD, and the presence of symptomatic flares alone does not impact sleep quality.
METHODS: Individuals ≥18 years of age, diagnosed with and on medication for IBD, were enrolled in an observational study, answered daily disease activity surveys, and wore a wearable device. Sleep architecture, sleep efficiency, and total hours asleep were collected from the devices. Inflammatory markers were collected as standard of care. Associations between sleep metrics and periods of symptomatic and inflammatory flares and combinations of symptomatic and inflammatory activity were compared with periods of symptomatic and inflammatory remission. The rate of change in sleep metrics for 45 days before and after inflammatory and symptomatic flares was explored.
RESULTS: A total of 101 participants were enrolled contributing a mean duration of 228.16 ± 154.24 nights of wearable data. Periods with active inflammation were associated with a significantly smaller percentage of sleep time in rapid eye movement and a greater percentage of sleep time in light sleep. Evaluating the intersection of inflammatory and symptomatic flares, altered sleep architecture was only evident when inflammation was present, and not with symptoms. Significant differences were observed in the rate that the percentage of time spent in deep and light sleep changed before and after inflammatory and symptomatic flares.
CONCLUSIONS: Impaired sleep architecture is associated with inflammatory activity in IBD, and the presence of symptomatic flares alone does not impact sleep quality.